Drug Profile
Interferon alpha-2a biosimilar - Profarma
Alternative Names: IFNa2a biosimilar - Profarma; PF-08 - ProfarmaLatest Information Update: 28 Jul 2019
Price :
$50
*
At a glance
- Originator Profarma
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Viral infections
Most Recent Events
- 28 Jul 2019 No recent reports of development identified for research development in Cancer in Lithuania (Parenteral)
- 28 Jul 2019 No recent reports of development identified for research development in Viral-infections in Lithuania (Parenteral)
- 17 Jun 2015 Early research in Cancer in Lithuania (Parenteral) (Profarma pipeline, June 2015)